X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
10
PharmaCompass offers a list of Liranaftate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Liranaftate manufacturer or Liranaftate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Liranaftate manufacturer or Liranaftate supplier.
PharmaCompass also assists you with knowing the Liranaftate API Price utilized in the formulation of products. Liranaftate API Price is not always fixed or binding as the Liranaftate Price is obtained through a variety of data sources. The Liranaftate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Liranaftate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Liranaftate, including repackagers and relabelers. The FDA regulates Liranaftate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Liranaftate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Liranaftate supplier is an individual or a company that provides Liranaftate active pharmaceutical ingredient (API) or Liranaftate finished formulations upon request. The Liranaftate suppliers may include Liranaftate API manufacturers, exporters, distributors and traders.
click here to find a list of Liranaftate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Liranaftate Drug Master File in Japan (Liranaftate JDMF) empowers Liranaftate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Liranaftate JDMF during the approval evaluation for pharmaceutical products. At the time of Liranaftate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Liranaftate suppliers with JDMF on PharmaCompass.
Liranaftate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Liranaftate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Liranaftate GMP manufacturer or Liranaftate GMP API supplier for your needs.
A Liranaftate CoA (Certificate of Analysis) is a formal document that attests to Liranaftate's compliance with Liranaftate specifications and serves as a tool for batch-level quality control.
Liranaftate CoA mostly includes findings from lab analyses of a specific batch. For each Liranaftate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Liranaftate may be tested according to a variety of international standards, such as European Pharmacopoeia (Liranaftate EP), Liranaftate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Liranaftate USP).
Market Place
